1) CORE diabetes model
CORE糖尿病模型
1.
METHODS:The CORE diabetes model was employed to evaluate the long-term cost-effectiveness of Acarbose in the treatment of type 2 diabetes.
方法:运用CORE糖尿病模型评价阿卡波糖治疗2型糖尿病的长期成本与效果。
2) diabetic model
糖尿病模型
1.
OBJECTIVE To explore the effect of Saponin extracted from Zea Mays L(ZMLS) on the morphologies of kidney,abdominal salivary gland,thoracic gland tissue for diabetic model rat induced by streptozocin(STZ).
kg-1造成的糖尿病模型大鼠为研究对象,将模型大鼠分为5组,分别灌服大、中、小剂量的玉米须总皂苷溶液、二甲双胍溶液和同体积生理盐水,另设一组空白对照组,给予同体积生理盐水。
2.
METHODS: Some animal models in this study included the glucose induced hyperglycemic model in mice, the alloxan induced diabetic model in mice and rats, and the HCSS induced insulin resistance model in mice.
方法 :用小鼠和大鼠建立葡萄糖性高血糖及四氧嘧啶性糖尿病模型 ,氢化可的松琥珀酸纳 (HCSS)诱导胰岛素抵抗 ,观察丹皮多糖 2b对正常和高血糖模型动物的影响 ,并测定糖尿病动物SOD、Insulin、GHb、ApoA1等水平。
3.
Objective To investigate the best experimental conditions of diabetic model induced by alloxan in Wistar rats.
结论 用四氧嘧啶制备糖尿病模型是一种经济可靠的实验方法。
4) mice
糖尿病模型
1.
Objective: To optimize the experimental conditions for establishing a diabetes mice model with alloxan.
目的:优化四氧嘧啶致小鼠糖尿病模型建立的实验条件;评价模型的稳定性。
2.
Objective:To optimize the experimental conditions for establishing a diabetes mice model with alloxan.
目的：优化四氧嘧啶致小鼠糖尿病模型建立的实验条件；评价模型的稳定性。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条